Lipid metabolic reprogramming in colorectal cancer: mechanisms and therapeutic strategies
Colorectal cancer (CRC) is the third most common cancer worldwide, and its high incidence, mortality, and treatment resistance highlight the urgency of exploring new therapeutic targets. As research into cancer metabolic reprogramming deepens, the central role of lipid metabolism abnormalities in CR...
Saved in:
| Main Authors: | Wujianhong Liu, Shengrong Dong, Feiran Hao, Yaohui Gao, Qing Wei |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1603032/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
FNDC5 and ACOX1 as Biomarkers of Peroxisomal Activity with Contrast Outcomes in Colon Adenocarcinoma
by: Yuan Hepei, et al.
Published: (2025-07-01) -
Metabolic reprogramming and immunosenescence in colorectal cancer: mechanisms and therapeutic implications
by: Jun Zhu, et al.
Published: (2025-08-01) -
Tertiary lymphoid structures in the microenvironment of colorectal cancer: exploring new therapeutic targets
by: Nan-Nan Dai, et al.
Published: (2025-06-01) -
Lipid metabolic reprogramming and associated ferroptosis in osteosarcoma: From molecular mechanisms to potential targets
by: Zhiyang Yin, et al.
Published: (2025-04-01) -
TIPE2 combined with immune cell infiltration predicts prognosis in colorectal cancer
by: Hengbo Xia, et al.
Published: (2025-07-01)